Status:
UNKNOWN
Treatment for Achilles Tendinopathy
Lead Sponsor:
University of Calgary
Collaborating Sponsors:
Sport Science Association of Alberta (SSAA)
Conditions:
Achilles Tendinopathy
Achilles Tendon Enthesopathy
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to determine whether sclerotherapy using a 25% dextrose and 1% lidocaine solution is an efficacious treatment for patients with chronic Achilles tendinopathy who have fail...
Detailed Description
The purpose of this research project is to optimize the clinical outcome of patients with Achilles tendinopathy. Patients who fail a standardized physical therapy regiment (eccentric training protocol...
Eligibility Criteria
Inclusion
- Adults 18 years of age and older with a minimum of 3 months of clinically determinant history and symptoms (pain) consistent with unilateral Achilles tendinopathy (enthesitis or mid-portion) as diagnosed by a sport medicine physician.
- Participants are not required to have tried other treatments, however, those who have tried other treatments (except injection treatments) including, but not restricted to, oral NSAIDs, topical NSAIDs, shoe modifications, and physical/athletic therapy will not be restricted from the study
- Provide informed consent for the controlled longitudinal study and RCT
Exclusion
- Individuals with physical ailments precluding them from performing the eccentric training program
- Worker's Compensation Board (WCB) and elite athletes (varsity, national and professional level).
- Individuals younger than 18 years of age will be excluded from this trial due to the complicating factors of musculoskeletal immaturity and the lack of relevant research of Achilles tendinopathy and neovascular bundles in this population.
- Previous Achilles tendon rupture of the tendon in question
- Individuals that have received any type of injection in or around the Achilles tendon
- Known allergy to dextrose based sclerosing agent or other contraindications
- Known allergy to Lidocaine
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT00835939
Start Date
September 1 2007
Last Update
February 4 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Calgary
Calgary, Alberta, Canada, T2N 1N4